Conditions: Asthma
Keywords: Asthma
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 311
Healthy volunteers: no

Brief summary:
To compare the efficacy of SYMBICORT® pMDI 160/4.5 μg x 2 actuations twice daily (bid) to that of budesonide inhalation powder DPI 180 μg x 2 inhalations bid, in African American(self-reported) subjects with inhaled corticosteroid (ICS) dependent asthma.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Budesonide / formoterol fumarate (SYMBICORT) intervention 2: Budesonide
Intervention descriptions: intervention 1: 160/4.5 μg x 2 actuations twice daily (bid) intervention 2: inhalation powder 180 μg x 2 inhalations bid (PULMICORT)

Protocol document: